Research Coordinator Clinical

Curriculum Vitae

*

Chia Arif

Mobile Phone: 713-***-****

Email: **********@*****.***

Education:

• USMLE (United States Medical License Exam) Step 3, January 26, 2022 (Passed)

• ECFMG Certified, Oct 2011.

• USMLE (United States Medical License Exam) Step 2 CK, Sep 2011, (Passed).

• USMLE (United States Medical License Exam) Step 2 CS (Clinical Skills), Jun, 2011

(Passed).

• USMLE (United States Medical License Exam) Step 1, Jun 2006 (Passed).

• Certified Clinical Research Coordinator, CCRC, April 2016.

• M.B.Ch.B-Sulaimani College of Medicine, Sulaimani City, Iraq, Jun, 1999. Membership and Honorary/Professional Societies:

American Academy of Neurology, Member (December 2012-Present). Academy of Clinical Research Professionals, Member (January 2016-Present). Iraqi Doctors Organization, Member (July 2001-Present). Kurdistan Medical Association, Member (August 2000-Present). Work experience:

7/1/2022 to preset Average Hours/Week: 80

PGY-3 at St. Mary Med Ctr-Langhorne-PA/Internal Medicine program 7/1/2021 to 7/1/2022 Average Hours/Week: 80

PGY-2 at St. Mary Med Ctr-Langhorne-PA/Internal Medicine program 7/1/2020-7/1/2021 Average Hours/Week: 80

PGY-1 at St. Mary Med Ctr-Langhorne-PA/Internal Medicine program Curriculum Vitae

2

09/2015 – 05/2020 Average Hours/Week: 40

Houston Methodist Neurological institute, Houston, TX, United States of America Senior Clinical Research Coordinator, William Ondo, M.D.

Oversee participant visits, including obtaining medical histories, reviewing and recording concomitant medications, executing clinical scales (MDS-URDRS, MoCa, and Suicide Severity Rating scales), performing ECGs, verifying patient eligibility, and reporting adverse effects. Present involvement includes extensive oversight of the following five clinical trials: study examining the long-term safety, tolerability, and efficacy of APL-130277 in Levodopa responsive patients with Parkinson's Disease complicated by motor fluctuations ("OFF" episodes); Study on effect of LY3154207 on Cognition in Mild-to-Moderate Parkinson’s Disease Dementia (PDD); study evaluating Bavisant's safety and efficacy in treatment of excessive daytime sleepiness in Parkinson's Disease; study evaluating the safety, pharmacokinetics, and pharmacodynamics of BIIB054 in subjects with early Parkinson's Disease; study investigating the efficacy, tolerability, and safety of two dosing regimens of continuous subcutaneous ND612 infusions.

Work experience:

03/2015 - 08/2015 Average Hours/Week: 40

University of Texas Health Science Center, Houston, TX, United States of America Clinical Research Coordinator, William Ondo, M.D.

Under the supervision of Dr. William Ondo, I managed participants enrolled in clinical trials. Tasks included obtaining patient medical histories, reviewing and recording concomitant medications, running clinical scales, performing ECGs, verifying participant eligibility, and reporting adverse events. Directly involved with two clinical trials, including a phase 3 randomized, double-blind, placebo-controlled study investigating the efficacy and safety of CVT-301 (levodopa inhalation powder) in Parkinson's Disease patients with motor response fluctuations (OFF Phenomena) and dystonia coalition national history and biorepository studies. 10/2013 - 02/2015 Average Hours/Week: 40

Northwest Heart Center, Houston, TX, United States of America Clinical Research Coordinator, Mustafa Mandviwala, M.D. Under the supervision of Dr. Mandviwala, I managed clinical trials, including obtaining patient medical histories, reviewing and recording concomitant medications, running clinical scales, performing ECGs, and identifying and verifying potential study participants and reporting adverse events. Oversaw two specific clinical trials: a phase III trial to confirm the anti-anginal effect of T89 in patients with stable angina (T89-07-CAESAR) and a double-blind, randomized, placebo-controlled, multicenter study assessing the impact of additional LDL-cholesterol reduction on major cardiovascular events when AMG 145 is used in combination with statin Curriculum Vitae

3

therapy in patients with clinically evident cardiovascular disease (AMG 145-******** - FOURIER trial).

08/2013 - 09/2013 Average Hours/Week: 40

University of Texas Health Science Center, Houston, TX, United States of America Neurology Observership, William Ondo, M.D.

As an observer under the supervision of Dr. William Ondo in the department of neurology at the University of Texas, I managed in-office cases. Observed physician interactions with patients and assisted with obtaining medical histories, executing physical and neurological examinations, determining diagnoses, and recommending corresponding treatment plans. Observership provided numerous opportunities to hone my interpersonal communication skills and enabled me to assess and treat patients more comprehensively. Work experience:

07/2013 - 08/2013 Average Hours/Week: 40

University of Texas Health Science Center, Houston, TX, United States of America Neurology Observership, Erin Furr-Stimming, M.D.

Under the supervision of Dr. Furr-Stimming, I completed an observership in the department of neurology at the University of Texas, overseeing in-office cases. Co-managed obtaining patient medical histories, executing physical and neurological examinations, provided diagnoses, and recommended corresponding treatments. Learned how to manage multiple patients concurrently. 10/2008 - 06/2013 Average Hours/Week: 40

Nerve and Muscle Center of Texas, Houston, TX, United States of America Clinical Research Coordinator, Aziz Shaibani, M.D. Managed clinical trials, including participant recruitment, verification of eligibility, and medical history obtainment. Ran clinical scales and performed nerve conduction studies, EMGs, and ECGs, and collected skin biopsies. Extensive involvement with eight clinical trials: study evaluating the efficacy and tolerability of JNJ-41260443 in subjects with diabetic painful neuropathy; study evaluating the analgesic efficacy of 28 days of oral administration of AZD2066 compared with placebo in patients with painful diabetic neuropathy; study assessing the safety of oral ranirestat in mild to moderate diabetic sensorimotor polyneuropathy; study monitoring subjects with ALS to determine the safety of SB-509; study comparing thymectomy to no thymectomy in nonthymomatous MG patients receiving prednisone; study evaluating efficacy and safety of SB-509 in patients with diabetic peripheral neuropathy (stem-cell mobilization); along with several more.

Curriculum Vitae

4

08/2003 - 03/2008 Average Hours/Week: 50

Sulaimani General Hospital, Sulaimani, Iraq

Attending Physician,

Assessed patient illnesses and determined diagnoses; obtained medical histories, performed physical examinations, and developed treatment plans. Gained extensive experience in direct patient care management and in overseeing a diverse patient population. Work experience:

08/1999 - 07/2003 Average Hours/Week: 70

Sulaimani General Hospital, Sulaimani, Iraq

Rotating Resident, Ali Saed, M.D., MRCP

As a rotating resident, I completed rotations in internal medicine, neurology, general surgery, pediatrics, obstetrics and gynecology, and psychiatry. While supervised by the attending physician, I delivered initial patient assessments and monitored them throughout the duration of their hospital stay. Tasks included obtaining detailed medical histories, performing physical examinations, and determining diagnostic test referrals. In addition, I recorded extensive progress notes, completed necessary patient procedures, and developed treatment plans through the guidance of the attending physician. Learned how to manage multiple complex patient plans concurrently.

Publications:

Peer Reviewed Journal Articles/Abstracts:

Arif, C., Shaibani, A.. Journal of Clinical Neuromuscular Disease. 32nd Annual Carrell-Krusen Symposium.. Inherited Fatty Acid Oxidation Disorder Resolves during Pregnancy.. 2010, Mar; 11(3): 18-18. Pub Status: Published.

Arif, C., Shaibani, A.. Journal of Clinical Neuromuscular Disease. 33rd Annual Carrell-Krusen Neuromuscular Symposium.. Muscle Twitching and Loss of Balance. 2011, Mar; 12(3): 23-23. Pub Status: Published.

Hannawi, Y. Arif, C., Shaibani, A.. Journal of Clinical Neuromuscular Disease. 32nd Annual Carrell-Krusen Symposium.. Five cases of Diplopia and Negative Brain Magnetic Resonance Imaging (MRIs).. 2010, Mar; 11(3): 4-4. Pub Status: Published. Curriculum Vitae

5

Ibraheim, H., Arif, C., Shaibani, A.. Journal of Clinical Neuromuscular Disease. 32nd Annual Carrell-Krusen Symposium.. Severe Muscle Cramps and Restlessness.. 2010, Mar; 11(3): 16-17. Pub Status: Published.

Jabari, D., Arif, C., Shaibani, A.. Journal of Clinical Neuromuscular Disease. 32nd Annual Carrell- Krusen Symposium.. Progressive Unilateral Spastic Hemiplegia.. 2010, Mar; 11(3): 9-10. Pub Status: Published.

Poster presentation:

Arif, C., Shaibani, A.. (March, 2013). Predictors of Muscle Biopsy outcomes in a Tertiary Neuromuscular Center Poster presented at: American Academy of Neurology 65th Annual Meeting; San Diego, CA, USA.

Hobbies & Interests:

I enjoy reading science books and novels, biking, and playing soccer. These activities allow me to rejuvenate my mind and body, respectively.

Other Awards/Accomplishments:

• Awarded a certificate for completing the MDS-UPDRS (Movement Disorder Society’s United Parkinson’s Disease Rating Scale) training program, by the International Parkinson and Movement Disorder Society (28/January/2018)

• Awarded a certificate for successfully completing the training and certification to administer and score the Montreal Cognitive Assessment, MoCA (26/January/2018)

• Certified Clinical Research Coordinator (CCRC)-Academy of Clinical Research Professionals (April, 2016)

Contact this candidate